Cofoe Medical Technology Co.,Ltd. (SHE:301087)
China · Delayed Price · Currency is CNY 54.94
-0.44 (-0.79%)
At close: Sep 23, 2026
Cofoe Medical Technology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 2,475 | 1,422 | 1,279 | 1,569 | 1,450 | 1,989 |
Trading Asset Securities | 586.67 | 1,017 | 1,357 | 851.3 | 1,243 | 1,537 |
Cash & Short-Term Investments | 3,062 | 2,439 | 2,636 | 2,421 | 2,693 | 3,527 |
Cash Growth | 26.27% | -7.50% | 8.90% | -10.12% | -23.63% | 533.03% |
Accounts Receivable | 416.58 | 444.79 | 401.84 | 486 | 617.22 | 362.02 |
Other Receivables | 76.45 | 61.37 | 47.52 | 30.63 | 46.15 | 32.42 |
Receivables | 493.03 | 506.15 | 449.36 | 516.63 | 663.37 | 394.44 |
Inventory | 787.8 | 675.5 | 659.58 | 634.72 | 529.36 | 480.75 |
Other Current Assets | 294.83 | 215.14 | 180.45 | 258.66 | 314.63 | 117.11 |
Total Current Assets | 4,638 | 3,835 | 3,925 | 3,831 | 4,201 | 4,519 |
Property, Plant & Equipment | 1,741 | 1,750 | 1,637 | 1,696 | 1,598 | 879.7 |
Long-Term Investments | 278.18 | 237.34 | 61.43 | 64.93 | 5.26 | 5.28 |
Goodwill | 368.91 | 368.91 | 364.34 | 242.41 | 230.5 | 48.59 |
Other Intangible Assets | 273.76 | 278.13 | 235.93 | 240.55 | 248.25 | 202.27 |
Long-Term Accounts Receivable | 4.71 | 4.93 | - | - | - | - |
Long-Term Deferred Tax Assets | 42.73 | 40.53 | 44.97 | 34.72 | 31.42 | 12.61 |
Long-Term Deferred Charges | 60.32 | 63.51 | 52.8 | 50.92 | 60.32 | 47.75 |
Other Long-Term Assets | 49.52 | 49.94 | 100.23 | 84.11 | 35.95 | 92.07 |
Total Assets | 7,457 | 6,629 | 6,423 | 6,244 | 6,411 | 5,807 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 766.7 | 639.05 | 467.65 | 482.97 | 634.89 | 448.1 |
Accrued Expenses | 116.77 | 118.1 | 95.89 | 92.09 | 144.45 | 58.84 |
Short-Term Debt | 758.26 | 574.75 | 548.61 | 402.43 | 282.74 | 83.07 |
Current Portion of Long-Term Debt | - | 125.08 | 114.01 | 12 | 13.81 | 10 |
Current Portion of Leases | 48.46 | 58.31 | 54.12 | 55.01 | 51.69 | 41.89 |
Current Income Taxes Payable | 17.21 | 3.9 | 17.8 | 3.76 | 28.47 | 23.31 |
Current Unearned Revenue | 26.99 | 29.31 | 2.13 | 16.84 | 8.98 | 10 |
Other Current Liabilities | 28.84 | 40.27 | 61.51 | 21.31 | 22.56 | 7.38 |
Total Current Liabilities | 1,763 | 1,589 | 1,362 | 1,086 | 1,188 | 682.58 |
Long-Term Debt | - | - | 125.17 | 94.1 | 30.03 | 5 |
Long-Term Leases | 60.94 | 68.04 | 61.48 | 77.24 | 84.55 | 93.19 |
Long-Term Unearned Revenue | 59.21 | 58.59 | 55.7 | 55.62 | 51.7 | 56.84 |
Pension & Post-Retirement Benefits | 2.74 | 2.88 | - | - | - | - |
Long-Term Deferred Tax Liabilities | 8.6 | 7.75 | 15.03 | 15.7 | 16.68 | 4.36 |
Other Long-Term Liabilities | - | - | 1.21 | 6.94 | 7.41 | - |
Total Liabilities | 1,895 | 1,726 | 1,620 | 1,336 | 1,378 | 841.97 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 235.9 | 208.9 | 209.09 | 209.24 | 208.49 | 160 |
Additional Paid-In Capital | 4,789 | 3,926 | 3,931 | 3,933 | 3,913 | 3,917 |
Retained Earnings | 830.53 | 874.29 | 868.67 | 923.4 | 914.88 | 869.8 |
Treasury Stock | -321.46 | -140.47 | -212.12 | -166.93 | -15.74 | - |
Comprehensive Income & Other | -7.31 | -1.55 | - | - | - | - |
Total Common Equity | 5,527 | 4,867 | 4,797 | 4,899 | 5,020 | 4,947 |
Minority Interest | 36 | 36.03 | 5.75 | 9 | 12.57 | 17.94 |
Shareholders' Equity | 5,563 | 4,903 | 4,802 | 4,908 | 5,033 | 4,965 |
Total Liabilities & Equity | 7,457 | 6,629 | 6,423 | 6,244 | 6,411 | 5,807 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 867.65 | 826.18 | 903.4 | 640.77 | 462.82 | 233.15 |
Net Cash (Debt) | 2,195 | 1,612 | 1,733 | 1,780 | 2,231 | 3,293 |
Net Cash Growth | 34.52% | -6.95% | -2.65% | -20.20% | -32.27% | 1133.06% |
Net Cash Per Share | 10.43 | 7.85 | 8.42 | 8.69 | 10.70 | 20.00 |
Filing Date Shares Outstanding | 227.13 | 203.2 | 203.39 | 203.7 | 203.94 | 208 |
Total Common Shares Outstanding | 228.7 | 203.2 | 203.39 | 205.04 | 203.94 | 208 |
Working Capital | 2,875 | 2,247 | 2,564 | 2,744 | 3,013 | 3,836 |
Book Value Per Share | 24.17 | 23.95 | 23.58 | 23.89 | 24.62 | 23.78 |
Tangible Book Value | 4,884 | 4,220 | 4,196 | 4,416 | 4,542 | 4,696 |
Tangible Book Value Per Share | 21.36 | 20.77 | 20.63 | 21.54 | 22.27 | 22.58 |
Buildings | 1,297 | 1,298 | 1,232 | 1,248 | 1,107 | 71.62 |
Machinery | 527.81 | 520.6 | 479.08 | 407.64 | 259.17 | 193.3 |
Construction In Progress | 191.06 | 138.63 | 50.13 | 49.33 | 171.39 | 508.49 |